[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368667-105":59,"doc-detail-368667-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","knockdown-of-pvt1-inhibits-cell-proliferation-in-luminal-and-basal-like-breast-cancer-subtypes-activating-lats2hippo-signaling-pathway","Knockdown of PVT1 inhibits cell proliferation in luminal and basal-like breast cancer subtypes - Activating LATS2/Hippo signaling pathway","","Breast cancer poses a major threat to women’s health, and drug resistance limits current therapies. This study investigates whether the long non-coding RNA PVT1 contributes to breast cancer pathogenesis and could support combined targeted treatment. Using public databases, bioinformatics, patient samples, and representative cell lines, PVT1 expression is assessed and its effects on proliferation are measured. RNA sequencing and functional assays show that PVT1 knockdown activates the LATS2/Hippo signaling pathway, increasing LATS2 and reducing nuclear YAP distribution, partly via mRNA stability regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/knockdown-of-pvt1-inhibits-cell-proliferation-in-luminal-and-basal-like-breast-cancer-subtypes-activating-lats2hippo-signaling-pathway/368667/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/knockdown-of-pvt1-inhibits-cell-proliferation-in-luminal-and-basal-like-breast-cancer-subtypes-activating-lats2hippo-signaling-pathway/368667.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study examine about PVT1 in breast cancer?","Question",{"text":112,"@type":113},"It examines whether PVT1 is abnormally expressed in breast cancer subtypes and whether its knockdown affects cancer cell proliferation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does PVT1 knockdown influence the LATS2/Hippo pathway?",{"text":117,"@type":113},"After PVT1 knockdown, both mRNA and protein levels of LATS2 increase, leading to reduced nuclear YAP distribution, indicating Hippo pathway activation.",{"name":119,"@type":110,"acceptedAnswer":120},"Which mechanism is proposed for how PVT1 regulates LATS2?",{"text":121,"@type":113},"The study investigates mRNA stability and shows that PVT1 knockdown significantly slows the degradation rate of LATS2 mRNA.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368667,1790302727,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Zhang et al. World Journal of Surgical Oncology (2025) 23:289  \n[https://doi.org/10.1186/s12957-025-03944-6](https://doi.org/10.1186/s12957-025-03944-6)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nKnockdown of PVT1 inhibits cell proliferation  in luminal and basal-like breast cancer  \nsubtypes by activating LATS2/Hippo signaling pathway  \nHai-Bo Zhang 1, Ying Zeng2 and Guo Wang3*  \nAbstract  \nBackground Breast cancer (BC) is a malignant tumor seriously threatening women’s health, while current approaches to BC treatment are challenged by the existence of drug resistance. Combination strategies of targeted therapy have been successfully applied in clinical BC treatment. However, whether there exist critical long non-coding RNAs (lncRNAs) responsible for BC pathogenesis and representing promising candidates for combined targeted therapy remains an issue.  \nMethods Public databases and bioinformatic methods were used to identify lncRNAs abnormally expressed among different subtypes of BC. The expression level of PVT1 was verified in collected clinical samples and representative cell lines. The role of PVT1 in BC cell proliferation was examined using MTS, plate clone formation, EdU and flow cytometry assay after small interfering RNA (siRNA) treatment. RNA sequencing was performed to investigate the potential molecular events regulated by PVT1 . Western blot and immunofluorescence experiments were used to verify the activation of LATS2/Hippo signaling pathway after PVT1 knockdown. In addition, its activation was confirmed to mediate PVT1 function through rescue assay. The regulatory effect of PVT1 on LATS2 was investigated using mRNA stability experiments.  \nResults The expression level of PVT1 in BC tissues of luminal and basal-like subtypes was significantly higher than that in paracancerous tissues. PVT1 knockdown substantially inhibited the proliferation of BC cells in both subtypes. RNA sequencing revealed that Hippo signaling pathway might be the downstream target of PVT1 . After PVT1 knockdown, both mRNA and protein level s of LATS2 were elevated which further decreased the distribution of  \nYAP in cell nucleus, indicating the activation of Hippo signaling pathway. The proliferation inhibitory effect of PVT1 could be attenuated by simultaneous knockdown of LATS2 . Furthermore, knockdown of PVT1 was demonstrated to significantly slow down the degradation rate of LATS2 mRNA.  \nConclusions PVT1 level was significantly elevated in luminal and basal-like BC subtypes. Knockdown of PVT1 could inhibit cell proliferation of these two BC subtypes partly through activating LATS2/Hippo signaling pathway.  \n*Correspondence: Guo Wang [207082@csu.edu.cn](207082@csu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nZhang et al. World Journal of Surgical Oncology (2025) 23:289 Page 2 of 16  \nKeywords PVT1, Hippo pathway, Luminal","cbCaip0CfqZdBSvs","https://ap.wps.com/l/cbCaip0CfqZdBSvs","pdf",2645392,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Breast cancer burden and treatment challenges\n## Molecular subtypes and targeted therapy background","[{\"question\":\"What does the study examine about PVT1 in breast cancer?\",\"answer\":\"It examines whether PVT1 is abnormally expressed in breast cancer subtypes and whether its knockdown affects cancer cell proliferation.\"},{\"question\":\"How does PVT1 knockdown influence the LATS2/Hippo pathway?\",\"answer\":\"After PVT1 knockdown, both mRNA and protein levels of LATS2 increase, leading to reduced nuclear YAP distribution, indicating Hippo pathway activation.\"},{\"question\":\"Which mechanism is proposed for how PVT1 regulates LATS2?\",\"answer\":\"The study investigates mRNA stability and shows that PVT1 knockdown significantly slows the degradation rate of LATS2 mRNA.\"}]","Knockdown of PVT1 inhibits cell proliferation in luminal and basal-like breast cancer subtypes - Activating LATS2/Hippo signaling pathway | PDF",1790177946,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e03db75160eea9627a1686ea5f723e14.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b53bf7f6b933d0392f90e8c9d8a34717.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f54f2d1ad5d805b1bb6669d910ccf80.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e72a9ecb2ba62c0871c8e3011fbe17c.webp",980,1306]